Corcept Therapeutics, Inc. (CORT)

43.92 +2.62 (+6.34%) USD  |  NASDAQ  |  Jan 23, 15:50
More

Corcept Therapeutics CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for CORT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
Axsome Therapeutics, Inc. Upgrade
Johnson & Johnson Upgrade
United Therapeutics Corp. Upgrade
Ultragenyx Pharmaceutical, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade